膈下逐瘀湯治療氣滯血瘀型盆腔炎性疾病后遺癥的臨床研究及對炎性細胞因子的影響
[Abstract]:Objective to observe the changes of TCM syndromes, symptoms and signs of (Sequelae of PID) patients with Qi stagnation and Blood stasis Type pelvic inflammatory Disease sequelae before and after treatment. Changes of serum inflammatory cytokine IL-1,IL-8,IL-10,TNF- 偽 expression and improvement of anxiety and depression in patients, Analysis and summary of clinical comprehensive curative effect and treatment mechanism of Gexiazhuyu decoction in treating pelvic inflammatory sequelae methods from November 2014 to November 2015, Qi-stagnation blood was selected from gynecological outpatient and inpatient of the first affiliated Hospital of Anhui University of traditional Chinese Medicine. 80 cases of pelvic inflammatory disease sequelae of blood stasis type, Among them, age 20, age 29, age 28, age 30, age 34, age 28, age 35, age 45, age 24. The course of disease ranged from 6 months to 21 cases, and from 1 year to 3 years, from 3 to 5 years. The patients were randomly divided into two groups according to the ratio of 1: 1. The patients were divided into treatment group (treated with Gexia Zhuyu decoction combined with wild chrysanthemum Tongluo enema granule retention enema) and control group (taking western medicine combined with ultrashort wave physiotherapy). Record the corresponding changes of TCM syndromes, clinical symptoms and local signs before and after treatment, analyze the comprehensive clinical efficacy, and record the changes of bad psychological emotions of the two groups before and after treatment. Changes of inflammatory cytokine IL-1,IL-8,IL-10,TNF- 偽 expression before and after treatment. Comprehensive evaluation of the two groups of pelvic inflammatory disease sequelae treatment results after treatment results: in the comprehensive curative effect, the total effective rate of the treatment group and the control group reached 85.0% and 82.5% respectively, the treatment group is better than the control group. The total effective rate of treatment group and control group were 95% and 90% respectively, the treatment group was superior to the control group. After statistical analysis, the curative effect of the treatment group has statistical significance (P0.01), the control group also has significant difference (P0.05); after the treatment of two groups of cases of TCM syndromes integral, There was no significant difference between the treatment group and the control group in the total score of TCM symptoms before treatment (P0.05). After treatment, the TCM syndrome score of the control group was higher than that of the treatment group (P0.05), and the TCM symptom score of the control group was lower than that of the former. The overall score of treatment group was significantly lower than that before treatment (P0.01). The treatment group was superior to the control group (p0.05). There was no significant difference in the scores of anxiety and depression between the two groups before treatment. After treatment, the depression and anxiety level of the two groups decreased significantly (p0.05), and the degree of depression in the treatment group was greater than that in the control group. The level of cytokines in the treatment group was better than that in the control group (p0.05). After treatment, IL-1,IL-8 was significantly lower than that before treatment (P0.05) and IL-10 was significantly higher than that before treatment (P0.05). There was no significant difference before and after treatment (P0.05). Conclusion Gexia Zhuyu decoction is effective in treating the sequelae of pelvic inflammatory disease of qi stagnation and blood stasis type, and can improve the clinical symptoms, local signs and TCM symptoms of patients with pelvic inflammatory disease. Can regulate the expression level of inflammatory cytokines, thereby improving the poor psychological state of patients.
【學位授予單位】:安徽中醫(yī)藥大學
【學位級別】:碩士
【學位授予年份】:2016
【分類號】:R271.9
【相似文獻】
相關(guān)期刊論文 前10條
1 許青媛;王惠成;;氣滯血瘀型冠心病患者的血脂變化[J];中西醫(yī)結(jié)合雜志;1985年05期
2 全順球;;參芎湯治療氣滯血瘀型肺心病心衰30例[J];中國中醫(yī)藥現(xiàn)代遠程教育;2010年07期
3 王昕耀;治氣滯血瘀型睪丸腫痛方[J];新中醫(yī);1985年02期
4 包文勝;香靈湯治療氣滯血瘀型痛經(jīng)病43例[J];河南醫(yī)藥信息;1997年02期
5 王東;;中藥治療氣滯血瘀型帶狀皰疹后遺神經(jīng)痛40例[J];現(xiàn)代醫(yī)藥衛(wèi)生;2007年04期
6 劉菁;劉光瑤;;中西醫(yī)結(jié)合治療氣滯血瘀型慢性盆腔炎性包塊80例臨床分析[J];四川中醫(yī);2008年01期
7 范新霞;;瓜蔞薤白半夏湯加味治療痰濁壅塞氣滯血瘀型冠心病慢性心力衰竭31例[J];河南中醫(yī);2012年09期
8 楊永暉;孫奎;蘇國宏;周忠良;;隔三七餅灸治療氣滯血瘀型膝原發(fā)性骨性關(guān)節(jié)炎臨床研究[J];中醫(yī)藥臨床雜志;2008年01期
9 楊大賦;楊穎;沈元良;諸伯星;;中西醫(yī)結(jié)合治療氣滯血瘀型原發(fā)性血小板增多癥20例[J];浙江中醫(yī)雜志;2013年09期
10 邱財榮;張琰;劉鋒;徐立清;陳崇尚;;玄歸止痛滴丸治療100例氣滯血瘀型胃痛的療效觀察[J];藥學服務與研究;2009年03期
相關(guān)會議論文 前7條
1 徐瑞生;宗序華;李小剛;;反射性交感神經(jīng)營養(yǎng)不良(氣滯血瘀型)的辨證施治[A];第十六屆全國中西醫(yī)結(jié)合骨傷科學術(shù)研討會暨中西醫(yī)結(jié)合手法治療骨傷科疾病新進展學習班論文匯編[C];2008年
2 李力強;黃勝英;賓建平;翟洪;;鱉甲消癥丸治療慢性乙型肝炎(氣滯血瘀型)的臨床研究[A];中國中西醫(yī)結(jié)合學會第十二次全國消化系統(tǒng)疾病學術(shù)研討會論文匯編[C];2000年
3 陳用軍;石年;王建;倪浩;;增色丸治療氣滯血瘀型白癜風臨床及試驗研究[A];2009全國中西醫(yī)結(jié)合皮膚性病學術(shù)會議論文匯編[C];2009年
4 楊洪英;徐春燕;周順文;段明;程韻洲;;淺談胃康膠囊和膽胃康膠囊治療氣滯血瘀型食道炎[A];中華中醫(yī)藥學會第二十二屆全國脾胃病學術(shù)交流會暨2010年脾胃病診療新進展學習班論文匯編[C];2010年
5 李延;李策;;降脂復肝湯治療氣滯血瘀型非酒精性脂肪肝的臨床觀察[A];第十八次全國中西醫(yī)結(jié)合肝病學術(shù)會議論文匯編[C];2009年
6 鄧倩萍;鄔志雄;;穴位貼敷治療氣滯血瘀型痛經(jīng)32例臨床觀察[A];廣東省針灸學會第十一次學術(shù)研討會論文匯編[C];2010年
7 溫冬艷;;針灸配合中藥治療氣滯血瘀型痛經(jīng)50例[A];廣東省針灸學會第十一次學術(shù)研討會論文匯編[C];2010年
相關(guān)重要報紙文章 前1條
1 今報;視各自體質(zhì)來養(yǎng)生[N];民族醫(yī)藥報;2003年
相關(guān)博士學位論文 前1條
1 楊士萱;針灸加藥物治療氣滯血瘀型肥胖癥臨床研究[D];廣州中醫(yī)藥大學;2008年
相關(guān)碩士學位論文 前10條
1 鄭曉艷;針刺治療氣滯血瘀型神經(jīng)性耳鳴的臨床療效觀察[D];福建中醫(yī)藥大學;2015年
2 李先蘭;淺針治療氣滯血瘀型帶狀皰疹后遺神經(jīng)痛臨床療效觀察[D];福建中醫(yī)藥大學;2015年
3 劉航;低溫等離子技術(shù)結(jié)合中藥治療氣滯血瘀型腰椎間盤突出癥的臨床研究[D];北京中醫(yī)藥大學;2016年
4 曾曉婷;翁麗麗教授中醫(yī)皮膚美容經(jīng)驗總結(jié)及活血祛斑湯治療氣滯血瘀型黃褐斑臨床觀察[D];福建中醫(yī)藥大學;2015年
5 宋爽;中醫(yī)綜合療法治療氣滯血瘀型帶狀皰疹(蛇串瘡)的回顧性分析[D];遼寧中醫(yī)藥大學;2016年
6 劉曉玲;針藥結(jié)合治療氣滯血瘀型輸卵管炎性阻塞性不孕癥的臨床療效觀察[D];安徽中醫(yī)藥大學;2016年
7 郭莉娜;膈下逐瘀湯治療氣滯血瘀型盆腔炎性疾病后遺癥的臨床研究及對炎性細胞因子的影響[D];安徽中醫(yī)藥大學;2016年
8 周瑞;中藥多途徑給藥治療氣滯血瘀型慢性盆腔炎臨床療效觀察及相關(guān)性研究[D];安徽中醫(yī)藥大學;2015年
9 朱玲;中藥分期治療氣滯血瘀型子宮內(nèi)膜不規(guī)則脫落的臨床觀察[D];安徽中醫(yī)藥大學;2015年
10 呂娜;疏肝化瘀法治療氣滯血瘀型盆腔炎性疾病后遺癥的臨床研究[D];黑龍江中醫(yī)藥大學;2011年
,本文編號:2239963
本文鏈接:http://sikaile.net/zhongyixuelunwen/2239963.html